Involvement of spinal tyrosine kinase in inflammatory and N-methyl-D-aspartate-induced hyperalgesia in rats

European Journal of Pharmacology

Volumn 468, Issue 3, 2003, Pages 191-198

  Sato, Eiru ^a   Takano, Yoshito ^a   Kuno, Yuichiro ^a   Takano, Manami ^a   Sato, Isao ^a  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antinociception; Inflammatory hyperalgesia; NMDA receptor; Spinal cord; Tyrosine kinase inhibitor

Indexed keywords

ANALGESIC AGENT; ANTINOCICEPTIVE AGENT; CARRAGEENAN; CYCLODEXTRIN; DIZOCILPINE; KAOLIN; LAVENDUSTIN A; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; THIAMYLAL;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; ENZYME INHIBITION; HYPERALGESIA; INFLAMMATION; MALE; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; TAIL;

EID: 0037837359     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01718-7     Document Type: Article

References (45)

1. Aanonsen L.M., Lei S., Wilcox G.L. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain. 41:1990;309-321.
2. Berg K.A., Maayani S., McKay R., Clarke W.P. Nerve growth factor amplifies cyclic AMP production in the HT4 neuronal cell line. J. Neurochem. 64:1995;220-228.
3. Cahusac P.M., Evans R.H., Hill R.G., Rodriquez R.E., Smith D.A. The behavioural effects of an N-methyl aspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology. 23:1984;719-724.
4. Carlson R.O., Aschmies S.H. Tyrosine kinase activity is essential for interleukin-1 beta-stimulated production of interleukin-6 in U373 human astrocytoma cells. J. Neurochem. 65:1995;2491-2499.
5. Chaplan S.R., Malmberg A.B., Yaksh T.L. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J. Pharmacol. Exp. Ther. 280:1997;829-838.
6. Chen H.S., Chen J. Secondary heat, but not mechanical, hyperalgesia induced by subcutaneous injection of bee venom in the conscious rat: effect of systemic MK-801, a non-competitive NMDA receptor antagonist. Eur. J. Pain. 4:2000;389-401.
7. Coderre T.J., Melzack R. Central neural mediation of secondary hyperalgesia following heat injury in rats: neuropeptides and excitatory amino acids. Neurosci. Lett. 131:1991;71-74.
8. Contreras M.L. Nerve growth factor stimulates the production of inositol 1,3,4- and 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate in PC12 cells. J. Neurochem. 61:1993;1035-1042.
9. Dickenson A.H., Aydar E. Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat. Neurosci. Lett. 121:1991;263-266.
10. Di Luca M., Gardoni F., Finardi A., Pagliardini S., Cattabeni F., Battaglia G., Missale C. NMDA receptor subunits are phosphorylated by activation of neurotrophin receptors in PSD of rat spinal cord. NeuroReport. 8(12):2001;1301-1305.
11. Dolan S., Nolan A.M. N-methyl D-aspartate induced mechanical allodynia is blocked by nitric oxide synthase and cyclooxygenase-2 inhibitors. NeuroReport. 10:1999;449-452.
12. Frerking M., Malenka R.C., Nicoll R.A. Brain-derived neurotrophic factor (BDNF) modulates inhibitory, but not excitatory, transmission in the CA1 region of the hippocampus. J. Neurophysiol. 80:1998;3383-3386.
13. Guo W., Zou S., Guan Y., Ikeda T., Tal M., Dubner R., Ren K. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J. Neurosci. 22:2002;6208-6217.
14. Hamakawa T., Woodin M.A., Bjorgum M.C., Painter S.D., Takasaki M., Lukowiak K., Nagle G.T., Syed N.I. Excitatory synaptogenesis between identified Lymnaea neurons requires extrinsic trophic factors and is mediated by receptor tyrosine kinases. J. Neurosci. 19:1999;9306-9312.
15. Himmelseher S., Ziegler-Pithamitsis D., Argiriadou H., Martin J., Jelen-Esselborn S., Kochs E. Small-dose S(+)-ketamine reduces postoperative pain when applied with ropivacaine in epidural anesthesia for total knee arthroplasty. Anesth. Analg. 92:2001;1290-1295.
16. Hirano A.A., Greengard P., Huganir R.L. Protein tyrosine kinase activity and its endogenous substrates in rat brain: a subcellular and regional survey. J. Neurochem. 50:1988;1447-1455.
17. Kang H., Schuman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science. 267:1995;1658-1662.
18. Kathirvel S., Sadhasivam S., Saxena A., Kannan T.R., Ganjoo P. Effects of intrathecal ketamine added to bupivacaine for spinal anaesthesia. Anaesthesia. 55:2000;899-904.
19. Kerr B.J., Bradbury E.J., Bennett D.L., Trivedi P.M., Dassan P., French J., Shelton D.B., McMahon S.B., Thompson S.W. Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord. J Neurosci. 19:1999;5138-5148.
20. Lei S., Dryden W.F., Smith P.A. Involvement of Ras/MAP kinase in the regulation of Ca2+ channels in adult bullfrog sympathetic neurons by nerve growth factor. J. Neurophysiol. 80:1998;1352-1361.
21. Lever I.J., Bradbury E.J., Cunningham J.R., Adelson D.W., Jones M.G., McMahon S.B., Marvizon J.C., Malcangio M. Brain-derived neurotrophic factor is released in the dorsal horn by distinctive patterns of afferent fiber stimulation. J. Neurosci. 21:2001;4469-4477.
22. Levine E.S., Crozier R.A., Black I.B., Plummer M.R. Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity. Proc. Natl. Acad. Sci. U. S. A. 95:1998;10235-10239.
23. Lin S.Y., Wu K., Levine E.S., Mount H.T.J., Suen P.C., Black I.B. BDNF acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical and hippocampal postsynaptic densities. Mol. Brain Res. 55:1998;20-27.
24. Lu W.Y., Xiong Z.G., Orser B.A., Dudek E., Browning M.D., MacDonald J.F. G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat. Neurosci. 2:1999;331-338.
25. Malcangio M., Garrett N.E., Gruwys S., Tomlinson D.R. Nerve growth factor- and neurotrophin-3-induced changes in nociceptive threshold and the release of substance P from the rat isolated spinal cord. J. Neurosci. 17:1997;8459-8467.
26. Mannion R.J., Costigan M., Decosterd I., Amaya F., Ma Q.P., Holstege J.C., Ji R.R., Acheson A., Lindsay R.M., Wilkinson G.A., Woolf C.J. Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9385-9390.
27. McMahon S.B., Bennett D.L.H., Michael G.J., Priestley J.V. Neurotrophic factors and pain. Jensen T.S., Turner J.A., Wiesenfeld-Hallin Z. Progress in Pain Research and Management. Proc. 8th World Congress on Pain. vol. 8:1997;353-379 IASP, Seattle, WA.
28. Meller S.T., Dykstra C., Gebhart G.F. Acute thermal hyperalgesia in the rat is produced by activation of N-methyl-D-aspartate receptors and protein kinase C and production of nitric oxide. Neuroscience. 71:1996;327-335.
29. Michael G.J., Averill S., Nitkunan A., Rattray M., Bennett D.L.H., Yan Q., Priestley J.V. Nerve growth factor treatment increases brain-derived neurotrophic selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J. Neurosci. 17:1997;8476-8490.
30. Millan M.J., Morris B.J., Colpaert F.C., Herz A. A model of chronic pain in the rat: high-resolution neuroanatomical approach identifies alterations in multiple opioid systems in the periaqueductal grey. Brain Res. 28(416):1987;349-353.
31. Onoda T., Iinuma H., Sasaki Y., Hamada M., Isshiki K., Naganawa H., Takeuchi T. Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus. J. Nat. Prod. 52:1989;1252-1257.
32. Ren K., Hylden J.L.K., Williams G.M., Ruda M.A., Dubner R. The effects of a non-competitive NMDA antagonist MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain. 50:1992;331-344.
33. Sato E., Takano Y., Sato I. Effects of intrathecally administered Trk inhibitor (K-252a) on carrageenan-induced mechanical allodynia in rats. 10th World Congress on Pain Abs. 2002;P60.
34. Snider W.D., McMahon S.B. Tackling pain at the source. New ideas about nociceptors. Neuron. 20:1998;629-632.
35. Subramaniam K., Subramaniam B., Pawar D.K., Kumar L. Evaluation of the safety and efficacy of epidural ketamine combined with morphine for postoperative analgesia after major upper abdominal surgery. J. Clin. Anesth. 13:2001;339-344.
36. Tezuka T., Umemori H., Akiyama T., Nakanishi S., Yamamoto T. PSD-95 promotes fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc. Natl. Acad. Sci. U. S. A. 96:1999;435-440.
37. Urban M.O., Coutinho S.V., Gebhart G.F. Involvement of excitatory amino acid receptors and nitric oxide in the rostral ventromedial medulla in modulating secondary hyperalgesia produced by mustard oil. Pain. 81:1999;45-55.
38. Wagner K.R., Mei L., Huganir R.L. Protein tyrosine kinases and phosphatases in the nervous system. Curr. Opin. Neurobiol. 1:1991;65-73.
39. Wang Y.T., Salter M.W. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature. 369:1994;233-235.
40. Woolf C.J., Thompson S.W. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain. 44:1991;293-299.
41. Yajima Y., Narita M., Narita M., Matsumoto N., Suzuki T. Involvement of a spinal brain-derived neurotrophic factor/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice. Brain Res. 958:2002;338-346.
42. Yamamoto T., Shimoyama N., Mizuguchi T. The effects of morphine, MK-801, an NMDA antagonist, and CP-96,345, an NK1 antagonist, on the hyperesthesia evoked by carrageenan injection in the rat paw. Anesthesiology. 78:1993;124-133.
43. Yang C.Y., Wong C.S., Chang J.Y., Ho S.T. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can. J. Anaesth. 43:1996;379-383.
44. Yang L.C., Marsala M., Yaksh T.L. Characterization of time course of spinal amino acids, citrulline and PGE2 release after carrageenan/kaolin-induced knee joint inflammation: a chronic microdialysis study. Pain. 67:1996;345-354.
45. Yu X.M., Askalan R., Keil G.J., Salter M.W. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science. 275:1997;674-678.